Selection of high-producing clones by a relative titer predictive model using image analysis

BACKGROUND: The commercial success of monoclonal antibodies (Mabs) has made biological therapeutics attractive to pharmaceutical companies. The priority of biopharmaceutical companies is to acquire and develop cell lines that enable them to manufacture biologics quickly, consistently, and economical...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Weihong, Ahmed, Waqas, Guo, Meijin, Mohsin, Ali, Wu, Bing, Li, Rongxiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350677/
https://www.ncbi.nlm.nih.gov/pubmed/34430585
http://dx.doi.org/10.21037/atm-21-2822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350677/
https://www.ncbi.nlm.nih.gov/pubmed/34430585
http://dx.doi.org/10.21037/atm-21-2822

Ejemplares similares